1y return+29.2%S&P 500 +20.9%
3y return+56.4%S&P 500 +68.5%
5y return+53.0%S&P 500 +74.5%
10y return+251.7%S&P 500 +256.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since June 30, 2016: $352 against $357 in the S&P 500.2
Farallon Capital Management, L.l.c.S&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| RVMDRevolution Medicines Inc | $2.5B | 15.0% | |
| Electronic Arts IncCUSIP 285512109 | $1.6B | 9.6% | +6.0% |
| BBIOBridgebio Pharma Inc | $800.1M | 4.7% | +14.7% |
| PTGXProtagonist Therapeutics Inc | $778.2M | 4.6% | |
| EXELExelixis Inc | $732.8M | 4.3% | +2.7% |
| LQDALiquidia Corporation | $666.9M | 3.9% | −3.4% |
| AMZNAmazon Com Inc | $627.5M | 3.7% | −37.6% |
| LNTHLantheus Hldgs Inc | $619.4M | 3.7% | |
| NTRANatera Inc | $602.2M | 3.6% | −30.8% |
| UNHUnitedhealth Group Inc | $528.1M | 3.1% | −30.3% |
| TMOThermo Fisher Scientific Inc | $526.0M | 3.1% | +19.0% |
| Roivant Sciences LtdCUSIP G76279101 | $506.4M | 3.0% | +47.9% |
| Aon PLCCUSIP G0403H108 | $458.6M | 2.7% | −45.0% |
| BSXBoston Scientific Corp | $449.0M | 2.7% | +40.8% |
| AVGOBroadcom Inc | $435.1M | 2.6% | −35.3% |
| MSFTMicrosoft Corp | $415.1M | 2.4% | −52.5% |
| TNGXTango Therapeutics Inc | $383.8M | 2.3% | +35.0% |
| KKRKkr & Co Inc | $378.0M | 2.2% | −11.8% |
| SNPSSynopsys Inc | $370.1M | 2.2% | −31.6% |
| BEAMBeam Therapeutics Inc | $351.3M | 2.1% | +1.0% |
| Crinetics Pharmaceuticals InCUSIP 22663K107 | $336.4M | 2.0% | +7.8% |
| GRALGrail Inc | $284.1M | 1.7% | +27.9% |
| WABWabtec | $241.2M | 1.4% | −44.4% |
| IMVTImmunovant Inc | $223.7M | 1.3% | +275.5% |
| TWSTTwist Bioscience Corp | $219.8M | 1.3% | +49.6% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| PTGXProtagonist Therapeutics Inc | June 30, 2020 | +594.1% | $778.2M |
| BTSGBrightspring Health Svcs Inc | March 31, 2024 | +541.6% | $120.8M |
| LQDALiquidia Corporation | March 31, 2024 | +440.5% | $666.9M |
| WABWabtec | June 30, 2020 | +368.4% | $241.2M |
| RVMDRevolution Medicines Inc | March 31, 2021 | +308.2% | $2.5B |
| Roivant Sciences LtdCUSIP G76279101 | June 30, 2023 | +251.1% | $506.4M |
| BBIOBridgebio Pharma Inc | September 30, 2024 | +192.5% | $800.1M |
| GHGuardant Health Inc | June 30, 2025 | +188.3% | $48.3M |
| NTRANatera Inc | June 30, 2021 | +139.1% | $602.2M |
| EXELExelixis Inc | June 30, 2020 | +129.2% | $732.8M |
Sold off last quarter
- SCHWSchwab Charles Corp was $371.8M
- GOOGAlphabet Inc was $285.8M
- VVisa Inc was $254.1M
- DISDisney Walt Co was $231.5M
- MAMastercard Incorporated was $217.4M
- MCKMckesson Corp was $202.8M
- Centessa Pharmaceuticals PLCCUSIP 152309100 was $191.0M
- TYRATyra Biosciences Inc was $137.1M
- THCTenet Healthcare Corp was $85.3M
- CAHCardinal Health Inc was $77.8M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +21.5% | +14.8% |
| March 31, 2026 | −5.1% | −4.6% |
| December 31, 2025 | +7.9% | +2.4% |
| September 30, 2025 | +3.8% | +7.8% |
| June 30, 2025 | +7.0% | +10.5% |
| March 31, 2025 | −2.7% | −4.6% |
| December 31, 2024 | +0.7% | +2.1% |
| September 30, 2024 | +9.7% | +5.4% |
| June 30, 2024 | −3.0% | +4.0% |
| March 31, 2024 | +7.0% | +10.0% |
| December 31, 2023 | +4.5% | +11.2% |
| September 30, 2023 | −3.0% | −3.6% |
| June 30, 2023 | +6.4% | +8.3% |
| March 31, 2023 | +4.9% | +7.0% |
| December 31, 2022 | +9.2% | +7.1% |
| September 30, 2022 | −6.6% | −5.3% |
| June 30, 2022 | −13.2% | −16.5% |
| March 31, 2022 | −5.5% | −4.9% |
| December 31, 2021 | +5.0% | +10.7% |
| September 30, 2021 | −0.2% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Farallon Capital Management, L.l.c. Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=909661&type=13F-HR&dateb=&owner=include&count=40CIK 909661
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/909661/000090883426000432/Filed August 14, 2026 · accession 0000908834-26-000432